; (ii) in clause (vi), by striking and at the end; (iii) in clause (vii), by striking the period and inserting ; and ; and (iv) by adding at the end the following new clause: (viii) in the case of the second study conducted under this paragraph, the quality of care, outcomes, costs, quantity and intensity of services, and other relevant metrics between individuals who entered into the Acute Hospital Care at Home initiative directly from an emergency department compared with individuals who entered into the Acute Hospital Care at Home initiative directly from an existing inpatient stay in a hospital. ; and (C) in paragraph (2)— (i) in the header, by striking Report and inserting Reports ; and (ii) by inserting and again not later than September 30, 2028, after 2024, ; and (iii) by striking on the study conducted under paragraph (1). and inserting the following: on— (A) with respect to the first report submitted under this paragraph, the first study conducted under paragraph (1); and (B) with respect to the second report submitted under this paragraph, the second study conducted under paragraph (1). . 105. Report on wearable medical devices Not later than 18 months after the date of the enactment of this Act, the Comptroller General of the United States shall conduct a technology assessment of, and submit to Congress a report on, the capabilities and limitations of wearable medical devices used to support clinical decision-making. Such report shall include a description of— (1) the potential for such devices to accurately prescribe treatments; (2) an examination of the benefits and challenges of artificial intelligence to augment such capabilities